GL1X · GenesisL1 explorer

UniProt A0A024R884

Tenascin C (Hexabrachion), isoform CRA_a (A0A024R884)

Tenascin C (Hexabrachion), isoform CRA_a (UniProt A0A024R884): 21 experimental structures on GenesisL1, 11 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
A0A024R884
Protein
Tenascin C (Hexabrachion), isoform CRA_a
Experimental structures
21
Predicted models
0
Ligands
11

Structures

21 records of A0A024R884 in the MolNFT archive: 21 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
5R5TPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARWS—
5R5UPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionANTV—
5R5UPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionANTV—
5R5VPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionAAXS—
5R5VPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionAAXS—
5R5WPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionAEJQ—
5R5WPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionAEJQ—
5R5XPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionARWV—
5R5XPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARWV—
5R5YPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionAJGG—
5R5YPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionAJGG—
5R5ZPanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionARX7—
5R5ZPandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARX7—
5R60PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionARXG—
5R60Pandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARXG—
5R61PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionAK1P—
5R61Pandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionAK1P—
5R62PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionARXJ—
5R62Pandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARXJ—
5R63PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN…x-ray diffractionARXS—
5R63Pandda analysis group deposition -- crystal structure of fibrinogen- like globe domain of human…x-ray diffractionARXS—

Ligands

  • AXS · 1-(4-fluorophenyl)-~{N}-[[(2~{R})-oxolan-2-yl]methyl]methanamine · in 2 records
  • EJQ · ~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide · in 2 records
  • JGG · N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide · in 2 records
  • K1P · 1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane · in 2 records
  • NTV · (2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide · in 2 records
  • RWV · 1-{1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl}methanamine · in 2 records
  • RX7 · 2-methyl-2-{[(3-methylthiophen-2-yl) methyl]amino}propan-1-ol · in 2 records
  • RXG · 2-(4-fluorophenoxy)-1-(1H-pyrrol-1-yl)ethan-1-one · in 2 records
  • RXJ · 4-(4-methylpiperazin-1-yl)benzonitrile · in 2 records
  • RXS · 3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile · in 2 records
  • RWS · 1-(5-methyl-1,3,4-thiadiazol-2-yl)piperidine · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.